Skip to main content
NUS logo

Nu Skin Enterprises, Inc. (NUS) Stock Price & Analysis

Nu Skin Enterprises, Inc. (NUS) — MoonshotScore 35/100 (Weak band), calculated Nov 18, 2026. Price $3.77 (-2.58%), as of the Nov 19, 2026 trading session; market cap $184M.

Educational signal · not a buy or sell recommendation · How to read this

$3.77 −$0.10 (-2.58%) Market Cap $184M

Nu Skin Enterprises, Inc. · NUS · NYSE

Nu Skin Enterprises, Inc. develops and distributes beauty and wellness products globally, focusing on skincare, nutritional supplements, and weight management. The company utilizes direct sales, distributors, and online channels to reach its customers.

Price as of Nov 19, 2026

Key Statistics

35 of 100

MoonshotScore v2 · Nu Skin Enterprises (NUS)

Weak
Business Quality Thin (25)
Financial Safety Strained (38)
Valuation Fair (61)
Growth Durability Shrinking (4)
Momentum Slipping (21)
Why this rating? Method, drivers & history

Bands for the MoonshotScore: Exceptional 80-100 · Strong 65-79 · Fair 45-64 · Weak below 45.

  • Business Quality — Is this a genuinely good business?
  • Financial Safety — Could this blow up on me?
  • Valuation — Am I paying a fair price?
  • Growth Durability — Is the growth real and likely to last?
  • Momentum — Is the market already moving on this?
The ten-second read ·

Weak quality, a strained balance sheet and stalling growth, and the price trend has turned against it. The score also carries a risk penalty for being loss-making and burning cash. Business Quality: Thin; Financial Safety: Strained; Valuation: Fair; Growth Durability: Shrinking; Momentum: Slipping.

  • quarterly revenue $311M (Q3 FY2026, quarter ended Sep 2026)
  • EPS beat 4 of the last 8 reports
  • Altman Z 3.67 · Piotroski F 4

Holding back: weak fundamentals, soft growth, weak price trend

What has the MoonshotScore done over time?

MoonshotScore snapshots recorded for NUS (57 recorded, newest six shown)
RecordedScoreBand
36Weak
36Weak
36Weak
36Weak
35Weak
35Weak

Daily score refresh is delayed. This is the last recorded calculation.

Calculation uses the most recent completed US trading session. Live price changes do not update the score immediately.

Computed · How the MoonshotScore is computed →

Price & valuation

Dates shown where recorded
MeasureValueAs of
Latest provided price$3.77
Change on the day-2.58%
52-week range$3.77 – $11.67
Market capitalisation$184M—
Price / earnings (trailing)4.73
Shares traded on the day797.3K

Price & events

Other perspectives

Council score for Nu Skin Enterprises (NUS): perspectives

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

5-Factor Breakdown

Business Quality Weak
Financial Safety Weak
Valuation Moderate
Growth Durability Negative
Momentum Weak

Legends Council

6 lenses, 0 current

AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built

Dalio-style lens (simulated) Ray Dalio Favorable read
Griffin-style lens (simulated) Ken Griffin Neutral read
Simons-style lens (simulated) Jim Simons Neutral read
Englander-style lens (simulated) Izzy Englander Favorable read
Klarman-style lens (simulated) Seth Klarman Favorable read
Moon AI lens (model) Favorable read

Read on: Nov 17, 2026 · older than the 27 hours refresh window; not a current reading

Munger's Mindset

Balance Sheet & Valuation · historical

Financial Health Negative
Margin of Safety Undervalued
Profit Margin Weak
Revenue Growth Negative
Debt/Equity Neutral
ROE Negative
Gross Margin Strong

Read on: Nov 16, 2026 · older than the 27 hours refresh window; not a current reading

How to read these bars and different assessments

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.

On Nov 16, 2026, the Munger lens read the price at that time as undervalued against its own estimate of value.

Readings on this page are from Nov 20, 2026, except a card that shows its own read date.

1 · What is it?

What is Nu Skin Enterprises (NUS), and what does it report?

Short answer

A current FMP business description is unavailable; the listing and provider classification below are the available identity facts. Nu Skin Enterprises, Inc. (NUS) is listed on NYSE. It employs 2,800 people and is led by Ryan S. Napierski. In Q3 FY2026 it reported revenue of $311M and net income of -$742,000. The market values it at $184M.

2 · Latest results

What do the latest results show for Nu Skin Enterprises (NUS)?

Short answer · as of

The most recent reported quarter, Q3 FY2026, carried revenue of $311M. Against analyst estimates the company has EPS beat 4 of the last 8 reports.

Quarterly income statement — 4 quarters
Revenue, net income and earnings per share by quarter
PeriodRevenueNet incomeEPS
Q3 FY2026$311M-$742,000-$0.02 (diluted)
Q2 FY2026$320M-$250M-$5.14 (diluted)
Q1 FY2026$321M$2M$0.04 (diluted)
Q4 FY2025$370M$14M$0.29 (diluted)
3 · Financial strengths and risks

What are the financial strengths and risks for Nu Skin Enterprises (NUS)?

Short answer · as of

What is holding it back is weak fundamentals, soft growth, weak price trend. The distress and quality screens read Altman Z 3.67 · Piotroski F 4. Trailing ratios: ROE -34.8% · ROA -21.5% · current ratio 2.04 · earnings yield -119.4% · free-cash-flow yield -13.4%.

5 · Peer comparison

How does Nu Skin Enterprises compare with its peers?

Short answer

Nu Skin Enterprises's score ranks 11th of 13 in the bounded comparison shown, against 12 same-model peers. These are company scores, not expected investment returns. The set lists named competitors first, then companies in the same data-provider industry classification closest in market value; that classification is the provider's, not our judgment of business similarity.

Peer set — price, market value and MoonshotScore
CompanyPriceMarket valueScore
Inter Parfums, Inc. (IPAR) Same industry, near in market value$133.73 Nov 18, 2026$4.28B96 5-pillar Nov 18, 2026
Spectrum Brands Holdings, Inc. (SPB) Same industry, near in market value$75.87 Nov 19, 2026$1.74B87 5-pillar Nov 18, 2026
AXIL Brands, Inc. (AXIL) Same industry, near in market value$4.50 Nov 19, 2026$30.7M84 5-pillar Nov 18, 2026
e.l.f. Beauty, Inc. (ELF) Same industry, near in market value$113.77 Nov 18, 2026$6.73B84 5-pillar Nov 18, 2026
United-Guardian, Inc. (UG) Same industry, near in market value$7.15 Nov 19, 2026$32.9M83 5-pillar Nov 18, 2026
Acme United Corporation (ACU) Same industry, near in market value$67.15 Nov 19, 2026$266M76 5-pillar Nov 18, 2026
Solésence, Inc. (SLSN) Same industry, near in market value$1.48 Nov 19, 2026$105M64 5-pillar Nov 18, 2026
The Clorox Company (CLX) Same industry, near in market value$104.90 Nov 19, 2026$12.7B60 5-pillar Nov 18, 2026
Helen of Troy Limited (HELE) Same industry, near in market value$35.09 Nov 19, 2026$821M59 5-pillar Nov 18, 2026
Edgewell Personal Care Company (EPC) Same industry, near in market value$27.57 Nov 19, 2026$1.27B38 5-pillar Nov 18, 2026
Nu Skin Enterprises (NUS) — this page$3.77$184M35
Tantech Holdings Ltd (TANH) Same industry, near in market value$41.24 Nov 19, 2026$27.5M34 5-pillar Nov 18, 2026
The Beauty Health Company (SKIN) Same industry, near in market value$12.15 Nov 19, 2026$79.2M27 5-pillar Nov 18, 2026

Only 5-pillar scores are ranked together. Other models are not directly comparable. Price and score dates are shown separately; market-value dates are unavailable.

The records behind this page

Insider activity

Form 4 records via FMP · Of the newest 100 records, those within the last 180 days, newest dated Sep 9, 2026

Transactions
2
Identified insiders
1
Purchases
0
Sales
0
Other transactions
2

Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent.

Who holds the shares?

Institutional ownership reported through 13F filings.

Tracked investors

Which of the 16 named investors we follow held NUS in their latest 13F filing, and what they did against the filing before it.

None of the 16 tracked investors reported NUS in their latest 13F filing.

See all tracked investor portfolios

How to read these figures

These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.

What has been published about Nu Skin Enterprises (NUS)?

Read these with our analysis →

Investor Questions: NUS Stock

These answers are editorial: 1 of these 9 answers is drawn from the NUS research dossier (written May 10, 2026 by gemini-2.0-flash); the other 8 are question templates that restate figures shown above. Figures in this section are not part of the source register.

What does the MoonshotScore mean for NUS?

NUS carries the MoonshotScore stated above — the Weak band. This is an educational research signal, not a buy or sell recommendation. The number comes from the five-pillar engine (business quality, financial safety, valuation, growth durability, momentum), re-ranked daily against sector peers.

Is NUS a good stock to buy?

Stock Expert AI does not rate NUS buy, sell or hold. Nu Skin Enterprises, Inc. carries a MoonshotScore, in the Weak band, a research rating against its peers rather than a forecast. Whether it fits is your call: check what it sells, whether it earns and what the price assumes. This is educational content, not investment advice.

What is the NUS stock price today?

The last price recorded for Nu Skin Enterprises, Inc. (NUS), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.

What do analysts say about NUS stock?

Analyst coverage of Nu Skin Enterprises, Inc. (NUS) is mixed, with some highlighting the company's potential for growth in emerging markets and its strong brand recognition.

What are the key factors to evaluate for NUS?

Nu Skin Enterprises, Inc. (NUS) holds a MoonshotScore in the low range. To weigh it, start with the trailing P/E under Price & valuation on this page. Strategic Partnerships and Acquisitions: Nu Skin can pursue strategic partnerships and acquisitions to expand its product portfolio, enter new markets, and gain access to new technologies. Not financial advice.

How frequently does NUS data refresh on this page?

NUS's price is the last quote we recorded, from the Nov 19, 2026 trading session. Pages are served from a cache, so the copy you are reading can lag that quote. The quote is a provider snapshot, not an exchange feed. Fundamentals follow quarterly filings. V2 is recalculated from the most recent completed US trading session; the score's own date shows its last successful run.

What has driven NUS's recent stock price performance?

Nu Skin Enterprises, Inc. (NUS) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Strong brand recognition in the beauty and wellness industry. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider NUS overvalued or undervalued right now?

The trailing P/E of Nu Skin Enterprises, Inc. (NUS) is listed under Price & valuation on this page. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

Can I buy fractional shares of NUS?

Fractional-share availability for Nu Skin Enterprises, Inc. (NUS) depends on your brokerage, account and supported securities. Check the broker's current eligibility, minimums and fees before placing an order.

Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated May 10, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.

Sources: the source register lists the 17 figures on this page — 9 from Financial Modeling Prep (FMP), 7 with no recorded source and 1 from Stock Expert AI's own score and rank. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.

Publication details and research sources
Published
Research standards
Methodology · Editorial policy · Corrections
Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.

ETFs that hold NUS

Funds in our ETF coverage that list NUS among the top 10 holdings on their fund page, largest weight first. Each weight is the fund's reported holding weight as of the date in its row.

ETFWeightHoldings as of
Validea Market Legends ETF (VALX)2.01%